Tsuchiya, Nanae
Schiebler, Mark L.
Evans, Michael D.
Cadman, Robert V.
Sorkness, Ronald L.
Lemanske, Robert F. Jr.
Jackson, Daniel J.
Jarjour, Nizar N.
Denlinger, Loren C.
Fain, Sean B. http://orcid.org/0000-0001-5461-0646
Funding for this research was provided by:
National Institutes of Health (U10 HL109168, P01 HL070831, R01 HL126771, S10 OD016394)
Article History
Received: 6 August 2019
Revised: 21 November 2019
Accepted: 19 December 2019
First Online: 24 January 2020
Compliance with ethical standards
:
: The authors of this manuscript declare relationships with the following companies: Mark L. Schiebler, MD, is a shareholder in Healthmyne and Stemina Biomarker Discovery; Sean B. Fain, PhD, receives grant support from GE Healthcare and serves on the scientific advisory board of Xemed.